Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

During the Trading Day
4.12 +0.295 / +7.72%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.15 +0.035 / +0.85%
 
Volume: 8.5K
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$369.1M

Company Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:

Employees

Shareholders

Mutual fund holders14.99%
Other institutional11.30%
Individual stakeholders1.61%

Top Executives

Gary S. JacobChairman, President & Chief Executive Officer
Bernard F. DenoyerSecretary, SVP-Finance & Head-Investor Relations
Kunwar ShailubhaiChief Scientific Officer & Executive VP
Patrick H. GriffinChief Medical Officer
Stephen ComiskeyVice President-Product Development

To view my watchlist

Not a member yet?

Sign up now for a free account